Cryo-Cell International has agreed to let Monash University in Australia use its menstrual stem cell technology in developing treatments for multiple sclerosis and other autoimmune diseases. The project will explore the possibility of using menstrual blood stem cells in removing or managing the autoreactive cells being linked to autoimmune diseases, one of the university researchers said.

Related Summaries